(Reuters) – U.S. drug reviewers said the serious heart, lung and liver side effects of Onyx Pharmaceuticals Inc’s carfilzomib drug may outweigh the experimental drug’s benefits for patients with a type of blood cancer.
JUMP
Blogs by, about, and for people who live with myeloma
(Reuters) – U.S. drug reviewers said the serious heart, lung and liver side effects of Onyx Pharmaceuticals Inc’s carfilzomib drug may outweigh the experimental drug’s benefits for patients with a type of blood cancer.
JUMP
